Testicular Cancer Clinical Trial
Official title:
Observational Study on the Quality of Life and Functional/Oncological Outcome of Patients Undergoing Surgery for Testicular Removal and/or Removal of Retro-peritoneal Lymph Nodes
The research aims to collect data in order to report the main problems related to the testicular cancer; To reach this aim, this study proposes to create a database of the testicular cancer condition. From this perspective, the aim of this project is the improving of scientific knowledge of the disease and develop appropriate and effective procedures for the diagnosis and treatment of the patient.
Status | Recruiting |
Enrollment | 3000 |
Est. completion date | August 31, 2040 |
Est. primary completion date | September 1, 2030 |
Accepts healthy volunteers | |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - subjects suffering from suspected neoplastic testicular pathology candidates for testicle removal surgery - patients suffering from neoplastic testicular pathology requiring removal of the retroperitoneal lymph nodes - subjects > 18 years old - subjects with at least elementary education - signature of informed consent Exclusion Criteria: - subjects < 18 years - presence of mental or physical disability that may prevent the patient from satisfying the requirements of the protocol |
Country | Name | City | State |
---|---|---|---|
Italy | IRCCS Ospedale San Raffaele | Milan | Lombardy |
Lead Sponsor | Collaborator |
---|---|
IRCCS San Raffaele |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical data | Collection of clinical data | Baseline | |
Primary | Adjuvant therapy | Which type of adjuvant therapy carried out (chemotherapy - radiotherapy - retroperitoneal lymphadenectomy) | Baseline | |
Primary | lactate dehydrogenase | Oncological follow-up through enzymatic value | Follow up after 6 months from baseline | |
Primary | Testicular objective examination | Number and size (via Prader orchidometer) of the testicles | Baseline | |
Primary | Testicular objective examination - cysts | Evaluation presence of cysts | Baseline | |
Primary | Testicular objective examination - nodules | Evaluation presence of nodules | Baseline | |
Primary | Testicular objective examination - varicocele | Evaluation presence of varicocele | Baseline | |
Primary | Testicular objective examination - hydrocele | Evaluation presence of hydrocele | Baseline | |
Primary | a-feto protein | Oncological follow-up through enzymatic value | Follow up after 6 months from baseline | |
Primary | ß human Chorionic Gonadotropin | Oncological follow-up through hormonal value | Follow up after 6 months from baseline | |
Primary | carcinoembryonic antigen | Oncological follow-up through hormonal value | Follow up after 6 months from baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00772694 -
Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
|
Phase 2 | |
Completed |
NCT00705094 -
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
|
N/A | |
Terminated |
NCT00531687 -
Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
|
Phase 2 | |
Terminated |
NCT00820287 -
Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
|
N/A | |
Completed |
NCT00216801 -
Relationship of Ochratoxin A to Upper Urologic Cancers
|
N/A | |
Active, not recruiting |
NCT03142802 -
Low-Dose CT - Stage I Testicular Cancer
|
N/A | |
Recruiting |
NCT03232541 -
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
|
N/A | |
Completed |
NCT03557177 -
Clinical Characterisation of the Vascular Effects of Cis-platinum Based Chemotherapy in Patients With Testicular Cancer
|
||
Active, not recruiting |
NCT01783145 -
Shared Care Follow-up After Chemotherapy for Testicular Cancer
|
||
Recruiting |
NCT05611307 -
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
|
||
Completed |
NCT02573584 -
Vascular Fingerprint Validation Study
|
||
Recruiting |
NCT05670938 -
Follow-up After Surgery for Testicular Cancer
|
||
Recruiting |
NCT02994758 -
Development of Diagnostics and Treatment of Urological Cancers
|
N/A | |
Completed |
NCT02991209 -
Study of Testosterone vs Placebo in Testicular Cancer Survivors
|
Phase 2/Phase 3 | |
Completed |
NCT02602041 -
Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
|
||
Completed |
NCT02092740 -
REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg
|
N/A | |
Completed |
NCT01482741 -
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
|
N/A | |
Active, not recruiting |
NCT01242072 -
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
|
Phase 1 | |
Completed |
NCT01242631 -
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
|
Phase 2 | |
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A |